Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C

Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C

Background/Aims Direct-acting antivirals (DAAs) effectively eradicate hepatitis C virus. This study investigated whether metabolic dysfunction influences the likelihood of fibrosis regression after DAA treatment in patients with chronic hepatitis C (CHC). Methods This multicenter, retrospective stud...

Full description

Saved in:
Bibliographic Details
Main Authors: Tom Ryu, Young Chang, Soung Won Jeong, Jeong-Ju Yoo, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Hong Soo Kim, Seung Up Kim, Jae Young Jang
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2025-04-01
Series:Clinical and Molecular Hepatology
Subjects:
direct-acting antivirals
liver fibrosis
regression
dyslipidemia
diabetes mellitus
Online Access:http://e-cmh.org/upload/pdf/cmh-2024-0904.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://e-cmh.org/upload/pdf/cmh-2024-0904.pdf

Similar Items